What is Weeks & Leo?
Established in 1892, Weeks & Leo operates as a cornerstone manufacturer of private label over-the-counter (OTC) pharmaceuticals. The company maintains a robust market position by supplying high-quality health and beauty products to major national retailers, including Walgreens, CVS, and Dollar General. Their extensive product portfolio spans critical categories such as First Aid, Lice treatment, Anti-Itch, Anorectal care, Pain management, and Cough & Cold remedies. Through a commitment to manufacturing excellence and value-driven distribution, the firm has cultivated a legacy of reliability that continues to serve as a primary differentiator in the retail pharmacy supply chain.
How much funding has Weeks & Leo raised?
Weeks & Leo has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Weeks & Leo
PPP
Public-Private Partnership
What's next for Weeks & Leo?
With the recent injection of capital, Weeks & Leo is positioned to accelerate its strategic growth initiatives, focusing on supply chain optimization and the expansion of its OTC product lines. As the company navigates the complexities of late-stage scaling, the focus will likely shift toward increasing manufacturing throughput and deepening partnerships with large-scale retail entities. This investment serves as a catalyst for long-term stability, enabling the firm to modernize its production infrastructure while maintaining the rigorous quality standards that have defined its century-long history. Future developments will likely center on operational efficiency and market share consolidation within the private label health sector.
See full Weeks & Leo company page
